Sort
326,823 grants matching “clinical trial”
ASPirin in Reducing Events in the Elderly
$4,941,881Anne M Murray · Hennepin Healthcare Research Institute · U01 · FY2017 · AG
Member Site Core
$4,938,597Peter J O'Dwyer · Ecog-Acrin Medical Research Foundation · U10 · FY2019 · CA
Multimodal MRI in Multiple Sclerosis
$4,937,262Daniel Reich · National Institute Of Neurological Disorders And Stroke · ZIA · FY2020 · NS
NIDA Clinical Trials Network: Big South/West Node Supplemental - CURB CTN0109 & KMD CTN0132
$4,935,061Madhukar H Trivedi · Ut Southwestern Medical Center · UG1 · FY2024 · DA
Univ. Michigan Comprehensive Cancer Center Support Grant
$4,934,319University Of Michigan At Ann Arbor · P30 · FY2002 · CA
Cancer Center Support Grant
$4,932,568Eric P Winer · Yale University · P30 · FY2024 · CA
Development/production of universal influenza vaccines
$4,931,770Jason Gall · National Institute Of Allergy And Infectious Diseases · ZIB · FY2025 · AI
General Clinical Research Center
$4,931,377Erik L Hewlett · University Of Virginia · M01 · FY2010 · RR
Trial-Ready Cohort for Preclinical/Prodromal Alzheimer's Disease
$4,929,565Paul S. Aisen · University Of Southern California · R01 · FY2020 · AG
Cancer and Leukemia Group B Statistical Center
$4,929,147Stephen L George · Duke University · U10 · FY2009 · CA
Clot Lysis: Evaluating Accelerated Resolution of IVH Phase III (CLEAR III)
$4,927,632Daniel F Hanley · Johns Hopkins University · U01 · FY2012 · NS
Diabetic Retinopathy Clinical Research Network
$4,927,170Roy W Beck · Jaeb Center For Health Research, Inc. · U10 · FY2008 · EY
LOGISTICAL AND IT SUPPORT FOR THE NCI CENTRAL INSTITUTIONAL REVIEW BOARD (CIRB)
$4,926,485Claudine Valmonte · The Emmes Company, Llc · N02 · FY2019 · CA
Harvard University Center for AIDS Research
$4,926,244Rajesh T Gandhi · Harvard University · P30 · FY2022 · AI
Allogeneic and Autologous Immunotherapy for cancer and nonmalignant hematological disorders
$4,926,222Richard Childs · National Heart, Lung, And Blood Institute · ZIA · FY2024 · HL
Building on the success of the adoptive immunotherapy of cancer
$4,924,486Nicholas Restifo · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Assessing Novel Biomarkers for Cognitive Fluctuations in DLB
$4,924,374Jagan Ayyappan Pillai · Cleveland Clinic Lerner Com-Cwru · RF1 · FY2025 · NS
REPRIEVE - CCC - Lead Application
$4,924,231Steven Kyle Grinspoon · Massachusetts General Hospital · U01 · FY2017 · HL
HIV PREVENTION TRIALS NETWORK LEADERSHIP GROUP
$4,923,564Family Health International · U01 · FY2002 · AI
The SPRINT Alzheimer's, Seniors and Kidney Study (SPRINT ASK)
$4,923,490David M Reboussin · Wake Forest University Health Sciences · R01 · FY2017 · AG
Prevention of OUD: The HOME (Housing, Opportunities, Motivation and Engagement) Randomized Trial
$4,922,920Natasha Slesnick · Ohio State University · UH3 · FY2020 · DA
Biology and therapy of C11orf95-RELA fusion-driven ependymoma
$4,906,170Eric C Holland · Fred Hutchinson Cancer Research Center · U54 · FY2019 · CA
A Phase 3 Pivotal Trial of AGB101 to Slow Progression in MCI due to Alzheimer's Disease
$4,903,985Richard C. Mohs · Agenebio, Inc. · R01 · FY2020 · AG
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
$4,902,816Henry N Ginsberg · Columbia University Health Sciences · UL1 · FY2008 · RR
Diabetes Prevention Program Outcomes Study
$4,902,199Sarah E. Fowler · George Washington University · U01 · FY2012 · DK